长期预后-话题@MedSci

#长期预后#

140篇内容 | 3639人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1645661, encodeId=9241164566109, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=Front Pharmacol：评估慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停综合征重叠综合征患者的长期预后, objectType=article, longId=220319, objectId=a421220319f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a421220319f1, replyNumber=0, likeNumber=0, createdTime=2021-11-23, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a421220319f1, moduleTitle=Front Pharmacol：评估慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停综合征重叠综合征患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a421220319f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645667, encodeId=bf33164566eca, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=J Clin Oncol：三阴性乳腺癌新辅助化疗加入卡铂或贝伐珠单抗并不能改善患者的长期预后（LTOs）, objectType=article, longId=294716, objectId=db94294e16ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db94294e16ed, replyNumber=0, likeNumber=87, createdTime=2022-12-04, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db94294e16ed, moduleTitle=J Clin Oncol：三阴性乳腺癌新辅助化疗加入卡铂或贝伐珠单抗并不能改善患者的长期预后（LTOs）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db94294e16ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645681, encodeId=dff51645681f4, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=Cardiovasc Diabetol：急性心肌梗死后糖尿病患者和非糖尿病患者入院后高血糖的短期和长期预后, objectType=article, longId=733001, objectId=ee4ee3300185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee4ee3300185, replyNumber=0, likeNumber=84, createdTime=2023-03-21, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee4ee3300185, moduleTitle=Cardiovasc Diabetol：急性心肌梗死后糖尿病患者和非糖尿病患者入院后高血糖的短期和长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee4ee3300185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645663, encodeId=d0a0164566367, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=三尖瓣反流速度评估肺动脉高压对瓣膜置换术后的长期预后意义, objectType=article, longId=221548, objectId=f9582215488d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9582215488d, replyNumber=0, likeNumber=89, createdTime=2022-06-20, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9582215488d, moduleTitle=三尖瓣反流速度评估肺动脉高压对瓣膜置换术后的长期预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9582215488d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645673, encodeId=307a16456e328, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=Lancet Oncol：派姆单抗 vs 化疗治疗微卫星不稳定性高/错配修复缺陷的转移性结直肠癌的长期预后, objectType=article, longId=724610, objectId=793de2461036, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=793de2461036, replyNumber=0, likeNumber=61, createdTime=2023-02-22, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=793de2461036, moduleTitle=Lancet Oncol：派姆单抗 vs 化疗治疗微卫星不稳定性高/错配修复缺陷的转移性结直肠癌的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=793de2461036)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645672, encodeId=9f6d16456e21e, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=Clin Cancer Res：晚期食管癌采用纳武单抗二线治疗的长期预后, objectType=article, longId=723436, objectId=90b1e23436f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90b1e23436f5, replyNumber=0, likeNumber=93, createdTime=2022-11-08, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90b1e23436f5, moduleTitle=Clin Cancer Res：晚期食管癌采用纳武单抗二线治疗的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90b1e23436f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645669, encodeId=6d6a1645669f7, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=AP&T:非侵入性方法对代谢相关脂肪肝患者的长期预后的预测能力评估, objectType=article, longId=300196, objectId=c7553001967b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7553001967b, replyNumber=0, likeNumber=102, createdTime=2022-09-30, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7553001967b, moduleTitle=AP&T:非侵入性方法对代谢相关脂肪肝患者的长期预后的预测能力评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7553001967b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645654, encodeId=f2281645654cc, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=Clin Cancer Res：复发/转移性非霍奇金淋巴瘤采用维奈托克治疗的长期预后, objectType=article, longId=215143, objectId=f0e9215143b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0e9215143b8, replyNumber=0, likeNumber=76, createdTime=2021-09-21, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0e9215143b8, moduleTitle=Clin Cancer Res：复发/转移性非霍奇金淋巴瘤采用维奈托克治疗的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0e9215143b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645671, encodeId=fd5016456e135, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=JAHA：支架内血栓形成后的长期预后和死亡的临床预测因素, objectType=article, longId=723596, objectId=08f1e235962e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08f1e235962e, replyNumber=0, likeNumber=72, createdTime=2022-10-15, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08f1e235962e, moduleTitle=JAHA：支架内血栓形成后的长期预后和死亡的临床预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08f1e235962e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645665, encodeId=df9416456650e, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=JACC：经导管肺动脉瓣置换术后的中期和长期预后, objectType=article, longId=293579, objectId=b52b2935e9de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b52b2935e9de, replyNumber=0, likeNumber=76, createdTime=2022-06-11, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b52b2935e9de, moduleTitle=JACC：经导管肺动脉瓣置换术后的中期和长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b52b2935e9de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645659, encodeId=0345164565904, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=JACC：肺动脉高压患者初始三联口服治疗可能改善长期预后, objectType=article, longId=218063, objectId=fe09218063c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe09218063c9, replyNumber=0, likeNumber=0, createdTime=2022-02-21, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe09218063c9, moduleTitle=JACC：肺动脉高压患者初始三联口服治疗可能改善长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe09218063c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645653, encodeId=e21e16456537c, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=J Clin Oncol：短程雄激素抑制和放疗剂量增加显著改善了中危前列腺癌患者的长期预后, objectType=article, longId=214997, objectId=4b2b21499e2d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b2b21499e2d, replyNumber=0, likeNumber=68, createdTime=2022-01-14, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b2b21499e2d, moduleTitle=J Clin Oncol：短程雄激素抑制和放疗剂量增加显著改善了中危前列腺癌患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b2b21499e2d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645657, encodeId=3fc3164565eca, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=Clin Cancer Res：利妥昔单抗+来那度胺→来那度胺治疗惰性非霍奇金淋巴瘤的长期预后, objectType=article, longId=216893, objectId=aac0216893ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aac0216893ff, replyNumber=0, likeNumber=101, createdTime=2022-07-18, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aac0216893ff, moduleTitle=Clin Cancer Res：利妥昔单抗+来那度胺→来那度胺治疗惰性非霍奇金淋巴瘤的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aac0216893ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645666, encodeId=9680164566648, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=JGH: 内镜下切除非壶腹十二指肠神经内分泌肿瘤的长期预后比较好, objectType=article, longId=294089, objectId=2ec7294089df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ec7294089df, replyNumber=0, likeNumber=0, createdTime=2022-03-10, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ec7294089df, moduleTitle=JGH: 内镜下切除非壶腹十二指肠神经内分泌肿瘤的长期预后比较好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ec7294089df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645649, encodeId=c6d21645649f3, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=Cardiovasc Diabetol：约2/3的无糖尿病病史的AMI患者有糖代谢紊乱，提示长期预后不良, objectType=article, longId=213038, objectId=38a021303808, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38a021303808, replyNumber=0, likeNumber=89, createdTime=2021-10-11, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38a021303808, moduleTitle=Cardiovasc Diabetol：约2/3的无糖尿病病史的AMI患者有糖代谢紊乱，提示长期预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38a021303808)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645662, encodeId=a257164566279, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=Clin Cancer Res：Tislelizumab治疗复发/难治性经典霍奇金淋巴瘤的长期预后, objectType=article, longId=220359, objectId=d3e4220359a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3e4220359a1, replyNumber=0, likeNumber=94, createdTime=2022-04-08, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3e4220359a1, moduleTitle=Clin Cancer Res：Tislelizumab治疗复发/难治性经典霍奇金淋巴瘤的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3e4220359a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645650, encodeId=bd7f164565069, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=JAMA Surg：新辅助放化疗联合手术可显著改善中国局部晚期食管鳞癌患者的长期预后, objectType=article, longId=213435, objectId=f68521343500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f68521343500, replyNumber=0, likeNumber=91, createdTime=2021-09-23, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f68521343500, moduleTitle=JAMA Surg：新辅助放化疗联合手术可显著改善中国局部晚期食管鳞癌患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f68521343500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645658, encodeId=ce6b1645658f6, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=Lancet Haemat：本妥昔单抗联合化疗治疗III/IV期经典霍奇金淋巴瘤的长期预后, objectType=article, longId=217739, objectId=0ff021e739a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ff021e739a7, replyNumber=0, likeNumber=91, createdTime=2022-08-14, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ff021e739a7, moduleTitle=Lancet Haemat：本妥昔单抗联合化疗治疗III/IV期经典霍奇金淋巴瘤的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ff021e739a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645642, encodeId=934d1645642ea, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=Lancet Respir Med：Tezacaftor-iVacaftor治疗携带CFTR Phe508del突变的囊性纤维化患者的长期预后, objectType=article, longId=207122, objectId=8d1120e122ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d1120e122ef, replyNumber=0, likeNumber=89, createdTime=2021-08-01, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d1120e122ef, moduleTitle=Lancet Respir Med：Tezacaftor-iVacaftor治疗携带CFTR Phe508del突变的囊性纤维化患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d1120e122ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645645, encodeId=758b164564582, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, objectTitle=JACC：采用Ross手术治疗的主动脉瓣疾病年轻患者的长期预后, objectType=article, longId=208928, objectId=b7ec2089280a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7ec2089280a, replyNumber=0, likeNumber=86, createdTime=2021-06-09, rootId=0, userName=ymljack, userId=0e4823226485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7ec2089280a, moduleTitle=JACC：采用Ross手术治疗的主动脉瓣疾病年轻患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7ec2089280a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

长期预后

2020-05-29

ymljack (审核中...)

前往app查看评论内容

#长期预后#

Front Pharmacol：评估慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停综合征重叠综合征患者的长期预后

2021-11-23

ymljack (审核中...)

前往app查看评论内容

#长期预后#

J Clin Oncol：三阴性乳腺癌新辅助化疗加入卡铂或贝伐珠单抗并不能改善患者的长期预后（LTOs）

2022-12-04

ymljack (审核中...)

前往app查看评论内容

#长期预后#

Cardiovasc Diabetol：急性心肌梗死后糖尿病患者和非糖尿病患者入院后高血糖的短期和长期预后

2023-03-21

ymljack (审核中...)

前往app查看评论内容

#长期预后#

三尖瓣反流速度评估肺动脉高压对瓣膜置换术后的长期预后意义

2022-06-20

ymljack (审核中...)

前往app查看评论内容

#长期预后#

Lancet Oncol：派姆单抗 vs 化疗治疗微卫星不稳定性高/错配修复缺陷的转移性结直肠癌的长期预后

2023-02-22

ymljack (审核中...)

前往app查看评论内容

#长期预后#

Clin Cancer Res：晚期食管癌采用纳武单抗二线治疗的长期预后

2022-11-08

ymljack (审核中...)

前往app查看评论内容

#长期预后#

AP&T:非侵入性方法对代谢相关脂肪肝患者的长期预后的预测能力评估

2022-09-30

ymljack (审核中...)

前往app查看评论内容

#长期预后#

Clin Cancer Res：复发/转移性非霍奇金淋巴瘤采用维奈托克治疗的长期预后

2021-09-21

ymljack (审核中...)

前往app查看评论内容

#长期预后#

JAHA：支架内血栓形成后的长期预后和死亡的临床预测因素

2022-10-15

ymljack (审核中...)

前往app查看评论内容

#长期预后#

JACC：经导管肺动脉瓣置换术后的中期和长期预后

2022-06-11

ymljack (审核中...)

前往app查看评论内容

#长期预后#

JACC：肺动脉高压患者初始三联口服治疗可能改善长期预后

2022-02-21

ymljack (审核中...)

前往app查看评论内容

#长期预后#

J Clin Oncol：短程雄激素抑制和放疗剂量增加显著改善了中危前列腺癌患者的长期预后

2022-01-14

ymljack (审核中...)

前往app查看评论内容

#长期预后#

Clin Cancer Res：利妥昔单抗+来那度胺→来那度胺治疗惰性非霍奇金淋巴瘤的长期预后

2022-07-18

ymljack (审核中...)

前往app查看评论内容

#长期预后#

JGH: 内镜下切除非壶腹十二指肠神经内分泌肿瘤的长期预后比较好

2022-03-10

ymljack (审核中...)

前往app查看评论内容

#长期预后#

Cardiovasc Diabetol：约2/3的无糖尿病病史的AMI患者有糖代谢紊乱，提示长期预后不良

2021-10-11

ymljack (审核中...)

前往app查看评论内容

#长期预后#

Clin Cancer Res：Tislelizumab治疗复发/难治性经典霍奇金淋巴瘤的长期预后

2022-04-08

ymljack (审核中...)

前往app查看评论内容

#长期预后#

JAMA Surg：新辅助放化疗联合手术可显著改善中国局部晚期食管鳞癌患者的长期预后

2021-09-23

ymljack (审核中...)

前往app查看评论内容

#长期预后#

Lancet Haemat：本妥昔单抗联合化疗治疗III/IV期经典霍奇金淋巴瘤的长期预后

2022-08-14

ymljack (审核中...)

前往app查看评论内容

#长期预后#

Lancet Respir Med：Tezacaftor-iVacaftor治疗携带CFTR Phe508del突变的囊性纤维化患者的长期预后

2021-08-01

ymljack (审核中...)

前往app查看评论内容

#长期预后#

JACC：采用Ross手术治疗的主动脉瓣疾病年轻患者的长期预后

2021-06-09

科室
- - 订阅+
  - 更多科室
工具
服务